Overview
What is The Ovarian Cancer Research Fund Inc?
The Ovarian Cancer Research Fund Inc, also known as OCRA, is a New York-based nonprofit organization dedicated to funding medical research, advocating for patients, and providing support and resources to those affected by ovarian cancer. With a mission to promote, advocate, and support scientific research on causes, prevention, diagnosis, treatment, and a cure for ovarian cancer, they have awarded over $113 million in grants to researchers at leading medical centers since 1998. Their investigators work on various fronts, including early detection, genetics, and developing new and better treatments. OCRA researchers have made significant strides in understanding ovarian cancer, such as discovering new therapeutic strategies and identifying biomarkers for monitoring treatment development. They also provide educational resources and support services to individuals and families affected by ovarian cancer. Through the generosity of donors, OCRA continues to make progress in the fight against this deadly disease.
Official website here: www.ocrahope.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 100% (Four-Star out of Four Stars)
The Ovarian Cancer Research Fund Inc (OCRF) has achieved an impressive four-star rating from Charity Navigator, signifying excellence in accountability and finance management. With a perfect score in accountability, the organization showcases a strong commitment to transparency and responsible use of funds. Its independent board, comprised entirely of 21 members, ensures strong governance, and the absence of any material diversions of assets reflects a high level of integrity.
User feedback on platforms like GreatNonprofits underscores OCRF's impact on individuals affected by ovarian cancer. Many reviews highlight the organization’s vital role in providing support and resources for both patients and their families. Survivors and family members express gratitude for the guidance and hope OCRF offers, emphasizing that the charity is deeply committed to advancing research aimed at early detection and treatment of ovarian cancer.
However, there are mentions of a desire for broader awareness around ovarian cancer, as it is often overshadowed by other cancer causes. Some reviewers have suggested that OCRF could benefit from increased visibility and outreach efforts to educate the public about the disease and its symptoms. Overall, OCRF is recognized as a crucial organization in the fight against ovarian cancer, with a strong reputation for effective fundraising and dedicated research initiatives.
This AI summary has been generated from information found on Charity Navigator and Great Nonprofits.
Is The Ovarian Cancer Research Fund Inc legitimate?
The Ovarian Cancer Research Fund Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Ovarian Cancer Research Fund Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $540,028
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,678,474
For more financial information, click here
Official website here: www.ocrahope.org
What is the mission statement of The Ovarian Cancer Research Fund Inc?
The Ovarian Cancer Research Fund Inc is dedicated to advocating for and supporting scientific research related to ovarian cancer, with the goal of discovering its causes, prevention, diagnosis, treatment, and ultimately, a cure. The organization provides education about the disease and offers supportive services to those affected by it. Additionally, The Ovarian Cancer Research Fund Inc fosters alliances to further these purposes, acting as a driving force in the fight against ovarian cancer.
Official website here: www.ocrahope.org
Who is the CEO of The Ovarian Cancer Research Fund Inc?
Audra L Moran is the Chair of The Ovarian Cancer Research Fund Inc. The CEO's salary of The Ovarian Cancer Research Fund Inc is $297,983 and their total compensation is $328,635.
Official website here: www.ocrahope.org
What is the revenue of The Ovarian Cancer Research Fund Inc?
The Ovarian Cancer Research Fund Inc's revenue in 2022 was $16,425,940.
Official website here: www.ocrahope.org
Who are the executives of The Ovarian Cancer Research Fund Inc and what are their salaries?
The average compensation at The Ovarian Cancer Research Fund Inc during 2022 was $76,500. There are 29 employees and 2107 volunteers at The Ovarian Cancer Research Fund Inc.
Here are 32 key members and their salaries (The Ovarian Cancer Research Fund Inc's CEO's salary is $297,983 and their total compensation is $328,635):
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $297,983
- Related: $0
- Other: $30,652
- Compensation: $185,000
- Related: $0
- Other: $26,393
- Compensation: $195,000
- Related: $0
- Other: $27,202
- Compensation: $175,000
- Related: $0
- Other: $28,235
- Compensation: $137,917
- Related: $0
- Other: $24,443
- Compensation: $122,689
- Related: $0
- Other: $24,119
- Compensation: $113,435
- Related: $0
- Other: $23,356
Official website here: www.ocrahope.org
Where can I find the form 990 for The Ovarian Cancer Research Fund Inc?
The Ovarian Cancer Research Fund Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.ocrahope.org
Learn more at the official website: www.ocrahope.org
Mission Statement of The Ovarian Cancer Research Fund Inc
The Ovarian Cancer Research Fund Inc, often referred to as OCRA, is a leading organization with a mission to make a significant impact on the fight against ovarian cancer. This nonprofit entity strives to promote, advocate for, and support scientific research related to the causes, prevention, diagnosis, treatment, and ultimately, the cure for ovarian cancer.
By championing research, OCRA aims to expand the understanding of this complex disease and contribute to the development of innovative solutions. Moreover, they provide vital education about ovarian cancer, ensuring that individuals and communities are informed and empowered to take action.
Furthermore, OCRA extends its support to those personally affected by ovarian cancer. Through its various programs and services, the organization offers assistance and resources to help survivors rebuild their lives and navigate their journey. OCRA fosters alliances with other organizations and stakeholders, fostering collaboration and furthering its objectives to create a world where ovarian cancer no longer poses a threat.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Ovarian Cancer Research Fund Inc (OCRA) has significantly impacted the fight against ovarian cancer since its inception in 1994. By funding medical research, advocating for patients, and providing support resources, OCRA addresses one of the deadliest forms of gynecologic cancer affecting thousands of women annually.
With over $113 million allocated to 398 research grants spanning 93 leading medical centers, OCRA empowers scientists and physicians to develop innovative strategies for early detection and treatment. This investment has yielded groundbreaking discoveries, such as the identification of biomarkers for monitoring disease progression, insights into the genetic factors that increase ovarian cancer risk, and advancements in treatment options that enhance patient survival and quality of life.
OCRA's researchers have shown that certain therapies, like rucaparib, can significantly extend progression-free survival for patients. They are also unraveling the complexities of drug resistance and exploring new therapeutic strategies tailored to various ovarian cancer subtypes. Recent findings suggest potential links between aspirin use and reduced ovarian cancer risk, while ongoing clinical trials aim to refine treatment protocols further.
Moreover, by fostering patient education and supportive services, OCRA not only addresses the medical challenges of ovarian cancer but also the emotional and practical needs of patients and their families. This holistic approach ensures that the fight against ovarian cancer is not just about research but about community support and patient empowerment as well.
Ultimately, OCRA's commitment to advancing ovarian cancer research and patient advocacy represents a vital effort to conquer this devastating disease and improve the lives of those affected. Every dollar contributed to OCRA aids in progressing one step closer to a cure, affirming its crucial role in the broader cancer research landscape.
This information is meant to be a general summary of The Ovarian Cancer Research Fund Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $755,651
- Program Service Revenue: $283,846
- Gross Receipts: $29,835,668
Assets and Liabilities:
- Total Assets: $37,659,088
- Total Liabilities: $14,828,822
- Net Assets: $22,830,266
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONFERENCE
Revenue
$283,846
Organization Details
Founding Year
1994
Phone
(212) 268-1002Principal Officer
Audra L Moran
Main Address
PO BOX 32141, NEW YORK, NY, 10087
Website
www.ocrahope.orgNTEE Category
Code: T70Z - Philanthropy
If you are a representative of The Ovarian Cancer Research Fund Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.